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Objective. To investigate the anthropometric indicators that can eﬀectively predict the nonalcoholic fatty liver disease (NAFLD).
Methods. The height, body weight, waist and hip circumference were measured, and body mass index (BMI), waist-to-height
(WHtR) and waist-to-hip ratio (WHR) were calculated. M-H chi square test, logistic regression analysis, and receiver-operating
characteristic (ROC) curve were employed for the analysis of risk factors. Patients or Materials. 490 patients were recruited, of
whom 250 were diagnosed as NAFLD and 240 as non-NAFLD (control group). Results. Compared with the control group, the
BMI, WHR, and WHtR were signiﬁcantly higher in patients with NAFLD. Logistic regression analysis showed that BMI and WHR
were eﬀective prognostic factors of NAFLD. In addition, WHR plays a more important role in prediction of NAFLD by the area
under curve. Conclusion. WHR is closely related to the occurrence of NAFLD. We assume that WHR is beneﬁcial for the diagnosis
NAFLD.
1.Introduction
Nonalcoholic fatty liver disease (NAFLD) is a cause of fatty
liver occurring when fat is deposited (steatosis) in the liver,
whereas not due to excessive alcohol use or other deﬁnite
injuriestotheliver.NAFLDisaclinicalsyndromeandpatho-
logicallycharacterizedbydiﬀusemacrovesicularfattychange
in the hepatocytes. NAFLD includes simple nonalcoholic
fatty liver disease, nonalcoholic steatohepatitis and hepatic
cirrhosis [1]. NAFLD is not static, and the NAFLD in the
childhoodmaydevelopintohepaticcirrhosisoverage,which
signiﬁcantly results in the increase of liver disease-related
mortality [2]. Early diagnosis and prompt treatment for
NAFLD are helpful to block or even reverse the development
of hepatic cirrhosis [3]. Liver biopsy has been a gold
standard in the clinical diagnosis of NAFLD, but it is invasive
and has sampling error and bias between observers which
signiﬁcantly limit the wide application of liver biopsy [4]. In
the present study, patients with pathologically and clinically
proven NAFLD were recruited, and the four anthropometric
indicators including waist circumference (WC), waist-to-hip
ratio (WHR), waist-to-height ratio (WHtR), and body mass
index (BMI) were determined. Our study aimed to ﬁnd
out eﬀective anthropometric indicators for the prediction of
NAFLD.
2. Patients andMethods
2.1. Ethics Statement. Our work was conducted in accor-
dance with the Declaration of Helsinki (1964). It was
approved by the Ethical Committee of Xiamen University
(XM2009-0003) and conformed to the National Institute of
Health guidelines on the clinical studies. Informed consent
was obtained from all patients.
2.2. Patients. A total of 250 patients with clinically and
pathologically proven NAFLD were recruited from the
Center for Liver Diseases of our hospital from 1 January
2008 to 29 June 2011. The NAFLD was diagnosed according
to the criteria for NAFLD [5], developed by the Society
of Hepatology of Chinese Medical Association [6]. There2 Gastroenterology Research and Practice
Table 1: Gender, age and anthropometric indicators in NAFLD group and non-NAFLD group (x ±s).
Clinical indicators Non-NAFLD group (n = 240) NAFLD group (n = 250) P
Age (yr) 37.32 ±10.19 36.60 ±11.14 0.62
Gender (male) 192 (80%) 189 (75.6%) 0.29
BMI 24.78 ±10.14 36.79 ±10.12 P<0.001
WHR 0.82 ±0.03 0.98 ±0.04 P<0.001
WHtR 0.44 ±0.08 0.59 ±0.06 P<0.001
Table 2: Correlation between BMI and NAFLD.
BMI (Kg/m2)B M I < 23.0 23.0 ≤ BMI < 25.0 BMI ≥ 25.0 Total
Xk 012
NAFLD group ak(
∗Tk) 10 (20.61) 62 (16.98) 178 (44.87) 250
Non-NAFLD group bk 149 (13.39) 43 (11.02) 48 (39.41) 240
Total 34 28 65 127
O R 1.0 21.83 29.92
χ2
MH — 20.53 56.83
95% CI — 5.24∼90.79 14.54∼222.15
∗Tk refers to the theoretical frequency corresponding to ak.
were 161 males and 89 females with a mean age of 36.60 ±
11.14 years (range: 15∼56 years). In addition, 240 patients
with non-NAFLD were also recruited in the same period
and served as controls. There were 96 patients with drug-
induced liver disease, 86 with toxic hepatitis, 19 with hepatic
hemangioma, and 39 with autoimmune liver disease. In the
control group, there were 192 males and 48 females with
am e a na g eo f3 7 .32 ± 10.19 years (range: 19∼58 years)
(Table 1). Exclusion criteria included coinfection with HBV,
HIV or HCV, alcohol consumption 30g/day. All patients
were deﬁned as persons who had negative hepatitis B surface
antigen (HBsAg) for at least 6 months before enrolling.
2.3. Detection of Anthropometric Indicators. Measurement
was done by the same experienced physicians who received
specialized training. The height, body weight, waist circum-
ference (WC), and hip circumference (HC) were measured.
Patients stood without wearing shoes but wearing ordinary
clothes. The WHR, WHtR, and BMI were calculated. BMI =
body weight/height2, WHR = WC/HC, WHtR = WC/height.
The WC and HC were measured at the level midway between
the lowest rib and the iliac crest and at the level of the great
trochanter.
2.4. Diagnostic Criteria: Criteria for Obesity. According to
the classiﬁcation of adult body weight by BMI in Asian
populations, 18.5kg/m2 ≤ BMI < 23.0kg/m2 was deﬁned
as normal, 23.0kg/m2 ≤ BMI < 25.0kg/m2 as overweight,
and BMI ≥ 25.0kg/m2 as obesity (peripheral obesity). WHR
of ≥0 . 9i nm a na n d≥0.8 in woman was deﬁned as central
obesity (+). WHtR of 0.5 was deﬁned as obesity.
2.5. Collection of Liver Samples. All patients received liver
biopsyunderultrasonographywithin1weekafteradmission.
Vacuum aspiration of liver tissues was done within 1 second
by using 14G Quick-cut needle (HAKKO Co., Ltd, Japan)
or Menghini needle. The liver tissues were 2cm in length,
and periportal areas were more than 10. The aspirated liver
tissues were ﬁxed in 10% neutral formaldehyde followed by
dehydration, embedding, and sectioning [7]. Hematoxylin-
eosin (HE) staining, Masson staining, and reticular ﬁber
staining were performed. Sections were analyzed by two
pathologists who were blind to the study. The diagnosis of
NAFLD was based on the criteria for NAFLD developed
by the Panel of Fatty Liver and Alcoholic Liver Disease of
Hepatology Branch of the Chinese Medical Association [6].
2.6. Statistical Analysis. Statistical analysis was performed
with SPSS version 13.0. Quantitative data were compared
with t test and qualitative data compared with chi square
test. In the present case-control study, risk factors were
categorized and the odds ratio (OR) and 95% conﬁdence
interval (CI) were calculated followed by statistical analysis
with Mantel-Haenszel χ2 test. For the multilevel BMI,
dose-reaction relation was employed for analysis of risk
factors. Bivariate logistic regression analysis was performed
to investigate the correlation between factors and NAFLD
in which the BMI, WHR, and WHtR were converted into
categoricalvariables.Partialmaximumlikelihood estimation
(forward selection method) was used for variable screening,
and model testing was done with likelihood ratio test. Single
regression coeﬃcient was tested with Wald test. ROC curve
was delineated with software. A value of P<0.05 was
considered statistically signiﬁcant.
3. Results
3.1. General Characteristics. Among these 490 patients, there
were 250 patients with NAFLD and 240 with non-NAFLD.Gastroenterology Research and Practice 3
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(a) ROC curve showing the performance of BMI in predicting NAFLD.
The AUC for BMI was 0.854 (95% CI 0.78 to 0.93)
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(b) ROC curve showing the performance of WHR in predicting
NAFLD. The AUC for WHR was 0.916 (95% CI 0.86 to 0.97)
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(c) ROCcurveshowingtheperformanceofWHtRinpredictingNAFLD.
The AUC for WHtR was 0.878 (95% CI 0.82 to 0.94)
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(d) ROC curve showing the performance of WC in predicting NAFLD.
The AUC for WC was 0.876 (95% CI 0.81 to 0.94)
Figure 1: ROC curve analysis of NAFLD-related indicators. (a) BMI; (b) WHR; (c) WHtR; (d) WC.4 Gastroenterology Research and Practice
Table 3: Correlation between WHR and NAFLD.
WHR group WHR ≥ 0.9 (man);
WHR ≥ 0.85 (woman)
WHR < 0.9 (man);
WHR < 0.85 (woman) Total
NAFLD group 189 61 250
Non-NAFLD group 43 197 240
Total 76 50 127
O R 30.52
χ2
MH 56.79
P 4.84E −14
95% CI 11.45∼81.39
Table 4: Correlation between WHtR and NAFLD.
WHtR group WHtR ≥ 0.5 WHtR < 0.5 Total
NAFLD group 185 65 250
Non-NAFLD group 86 154 240
Total 89 38 127
O R 21.04
χ2
MH 42.69
P 6.40E −11
95% CI 7.63∼57.98
Table 5: Risk factors and standardization of risk factors.
Risk factors Standardization
BMI BMI of < 23 as 0 BMI of < 25 and ≥23 as 1;
BMI of ≥ 25 as 2
WHR
WHR of < 0.9 (man);
WHR of < 0.85
(women) as 0
WHR ≥ 0.9 (man);
WHR ≥ 0.85 (woman) as 1
WHtR WHtR of < 0.5 as 0 WHtR ≥ 0.5 as 1
The mean age was 37.32 ± 10.19 years in NAFLD patients
and 36.60 ± 11.14 years in non-NAFLD patients showing no
signiﬁcant diﬀerence (F = 0.69, P = 0.41; t = −0.49, P =
0.62).IntheNAFLD,therewere189malesand61females.In
thenon-NAFLD group,there were192 malesand48females.
There was no marked diﬀerence in the gender between two
groups (χ2 = 1.12, P = 0.29). In the NAFLD group, the (t =
8.34, P<0.001), WHR (t  = 10.42, P<0.001) and WHtR (t 
= 9.10, P<0.001) were dramatically higher than those in the
non-NAFLD group (Table 1).
3.2. Correlation between BMI, WHR and WHtR and NAFLD.
BMI, WHR and WHtR were the risk factors of NAFLD
(Tables 2, 3, 4). When the BMI was ≥23.0 but <25.0, the OR
was 21.83 (95% CI: 5.24∼90.79; χ2
MH = 20.53; P<0.001).
When the BMI ≥ 25.0, the OR was 29.92 (95% CI: 14.54∼
222.15; χ2
MH = 56.83; P<0.001). Furthermore, the OR
increased with the elevation of BMI (χ2 = 25.03, P<0.001).
The OR of WHR was 30.52 (95% CI: 11.466∼81.39; χ2
MH =
56.79; P<0.001). The OR of WHtR was 21.04 (95% CI:
7.63∼57.98; χ2
MH = 42.69; P<0.001) (Table 5).
3.3. Bivariate Logistic Regression Analysis. NAFLD was
deﬁned as the endpoint. At the same time the criteria such as
age, gender, height, body weight, WC, HC, the standardized
BMI, WHR, and WHtR were applied for logistic regression
analysis (Table 6). Partial maximum likelihood estimation
with forward selection method was used for the screening
of variables. Results showed BMI (O Rj = 11.76) and
WHR (O Rj = 3.09) were two eﬀective indicators for the
prediction of NAFLD, and the probability equation was P
= e−2.239 + 1.130BMI + 2.464WHR/(1 + e−2.239 + 1.130BMI + 2.464WHR),
(χ2 = 74.82, P<0.001).
3.4. ROC Curve Analysis of NAFLD-Related Indicators.
BMI (AUC = 0.854, Figure 1(a)), WHR (AUC = 0.916,
Figure 1(b)), WHtR (AUC = 0.878, Figure 1(c)), and WC
(AUC = 0.876, Figure 1(d)) had diagnostic value for NAFLD
andtheWHRhadthelargestAUCandthehighestdiagnostic
value. When the cutoﬀ value was 0.891, the Youden index
(sum of sensitivity [0.987] and speciﬁcity [0.660]) was the
largest (Table 7).
4. Discussion
In recent years, BMI, WHR, and abdominal circumference
arechangedsigniﬁcantlywiththeelevationoflivingstandard
and changes in the lifestyle, and the mean BMI in adults
is increasing in both developed and developing countries.
Currently,thereareabout1.46billionand0.5billionsubjects
with overweight and obese, respectively [8]. In addition,
in USA, overweight people account for 60% of adults and
obesity subjects for 25% of adults, and overweight and
obesity have been important heath problems in children and
adolescents [9]. The incidence of NAFLD is increasing, and
NAFLD has become a common chronic liver disease and a
critical problem threatening the human health. NAFLD has
been conﬁrmed to be closely related to the hyperlipidemia,
hypertension, type 2 diabetes, cardiovascular diseases, and
some malignancies [10]. In China, the NAFLD has become
the second leading liver disease following viral hepatitis,
which is similar to the condition in western countries [11].
The incidence of NAFLD is as high as 60% ∼90% in obese
subjects, and the prevalence of NASH and hepatic cirrhosis
was 20% ∼25% and 2% ∼8%, respectively [12]. In NAFLDGastroenterology Research and Practice 5
Table 6: Logistic analysis of risk factors of NAFLD.
Partial regression coeﬃcient B Standard error Wald χ2 P O R 95% CI
WHR 2.464 0.563 19.148 1.210E −3 11.757 3.899∼35.454
BMI 1.130 0.355 10.127 0.001 3.094 1.543∼6.204
Constant −2.239 0.496 20.373 6.374E −6 0.107
Cox and Snell R2 0.445
Nagelkerke R2 0.603
Discriminant eﬀectiveness 85%
Table 7: Sensitivity, speciﬁcity and AUC of cutoﬀ value of anthropometric indicators in prediction of NAFLD.
Anthropometric indicators Cutoﬀ value Youden index Sensitivity Speciﬁcity AUC 95% CI P
BMI 24.22 0.610 0.96 0.640 0.854 0.78∼0.93 1.867E −3
WHR 0.89 0.703 0.99 0.660 0.916 0.86∼0.97 2.621E −3
WHtR 0.49 0.601 0.96 0.640 0.878 0.82∼0.94 7.233E −3
WC 82.50 0.628 0.95 0.680 0.876 0.81∼0.94 9.139E −3
patients, the incidence of type 2 diabetes is signiﬁcantly
increased, and the NAFLD is closely associated with malig-
nanciesandcanpromotetheoccurrenceanddevelopmentof
atherosclerotic cardiovascular diseases [13]. Recently, more
attention has been paid to the prevention and treatment
of overweight and obesity in clinical practice. In addition,
there is evidence showing that insulin resistance is closely
related to the NAFLD and has been a hot topic in researches
on NAFLD. Clinically, to determine the insulin resistance
is critical, but detection of insulin level is invasive, and
there is still no reference range for insulin resistance. These
signiﬁcantlylimitthewideapplicationofdetectionofinsulin
resistance. Liver biopsy has become a gold standard in the
diagnosis of NAFLD, but it is invasive. Currently, abdominal
color Doppler ultrasonography is used for the noninvasive
diagnosis of NAFLD, and this technique still has limitations
due to the low consistence with pathological ﬁndings. Thus,
it is imperative to develop simple and sensitive indicators for
thediagnosisofNAFLD.Inthepresentstudy,WHRwasused
as an indicator of central obesity and the eﬀect of WHR on
the NAFLD was investigated. To better predict the NAFLD
in high-risk population, the pathological ﬁndings were used
as the main standard for the diagnosis of NAFLD, and the
anthropometric indicators were also measured.
In the present study, WC, WHR, WHtR, and BMI
were measured, and statistical analysis showed WHR had
advantages in the prediction of NAFLD over WC, WHtR,
and BMI. In addition, logistic analysis and ROC curve
analysis also revealed WHR had the largest OR (11.757),
suggesting WHR is a critical anthropometric indicator for
the prediction of NAFLD. However, WC and WHtR were
not included into the equation. In the analysis of NAFLD
with the ROC curve, WHR had the largest AUC (0.916)
and thus had the best diagnostic value. When the cutoﬀ
of WHR was 0.89, the sensitivity and speciﬁcity were 0.99
and 0.66, respectively. NAFLD is closely related to the
metabolic syndrome. Studies have shown that WHtR and
WC are the main risk factors used for the evaluation of
metabolic syndrome and coronary heart disease [14, 15]. A
study on the correlation between WHR and cardiovascular
events revealed WHR was a risk factor that could increase
the risk for cardiovascular events [16]. Investigators have
indicated WHR is a good anthropometric indicator for the
prediction of type 2 diabetes [17]. Diabetes is associated with
cardiovascular and cerebrovascular events. In a prospective
study on diabetes revealed WHR was an important indicator
that could predict the risk for cardiovascular events in type 2
diabetes patients [18]. Our results show WHR is a risk factor
of NAFLD which indicates central obesity is closely related
to the occurrence of NAFLD. WHR is the most important
anthropometric indicator for the prediction of NAFLD and
independent of other risk factors, which is consistent with
previously reported [19]. Moreover, our ﬁndings also reveal
BMI also has value in the prediction of NAFLD, and BMI,
WHR, and WHtR are closely associated with the occurrence
of NAFLD (Tables 2, 3,a n d4). In the study of Aekplakorn
et al. [20], results showed WC, WHR, and WHtR had minor
advantages in the prediction of cardiovascular events over
BMI in Thai population. However, in the Caucasian of USA
and Europe, BMI has advantage in the prediction of type 2
diabetes over other indicators [21]. In addition, the ethnic
diﬀerence may also aﬀect the selection of indicators for
the prediction of NAFLD. Furthermore, there is evidence
showing that the prediction of cardiovascular events with
WHRdependsonthegender[21].Studiesonthegeneticand
environmental factors revealed the morbidity and outcome
of NAFLD varied from regions and races [22]. In the present
study, although logistic regression was used to adjust the
confounding factors including gender, our ﬁndings had
the tendency to predict NAFLD in males due to the high
proportion of males. Our ﬁndings may be more useful in the
prediction of NAFLD in males. WHR is simple to measure
and thus can be applied as an important anthropometric
indicator to screen population with high risk for NAFLD
which is beneﬁcial for the diagnosis and treatment of
NAFLD.6 Gastroenterology Research and Practice
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